Author:
Donato Michele L.,Siegel David S.,Vesole David H.,McKiernan Phyllis,Nyirenda Themba,Pecora Andrew L.,Baker Melissa,Goldberg Stuart L.,Mato Anthony,Goy Andre,Rowley Scott D.
Subject
Transplantation,Hematology
Reference31 articles.
1. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma;Richardson;N Engl J Med,2005
2. An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naïve patients with relapsed and/or refractory multiple myeloma;Vij;Blood,2012
3. Continuous lenalidomide treatment for newly diagnosed multiple myeloma;Palumbo;N Engl J Med,2012
4. Phase I study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib;Richardson;Blood,2013
5. National Cancer Institute, Surveillance, Epidemiology and End Results Program (SEER) data 2003-2009. Available at: http://seer.cancer.gov/statfacts/html/mulmy.html.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献